{"anticipatedPostingDate":"2028-10","denomUnitsSelected":"Participants","description":"Molecular response is assessed using BCR-ABL transcript levels measured by realtime quantitative polymerase chain reaction. MMR is defined as a ratio BCR-ABL/ABL ≤0.1% on the international scale (ie, at least 3 log reduction from a standardized baseline value).","reportingStatus":"NOT_POSTED","timeFrame":"at 96 weeks (96 weeks after last patient first dose)","title":"Major Molecular Response at Week 96","type":"SECONDARY"}